Abstract.
Familial hypertrophic cardiomyopathy is an autosomal dominant disease with a wide range of clinical features from benign to severe, and is the most common cause of sudden death in otherwise healthy individuals. The two prominent clinical features are left ventricular hypertrophy and myocyte/myofibrillar disarray. The former is responsible for clinical symptoms such as breathlessness and angina, whereas the latter may lead to sudden cardiac death. The last decade has seen an enormous improvement in our understanding of the molecular genetics of this disorder. The clinical heterogeneity has been linked to genetic heterogeneity; mutations in nine genes encoding sarcomere proteins have been shown to be the molecular basis for the disorder. However, attempts to establish a genotype–phenotype correlation for each of the more than 100 mutations that have been identified have not been highly successful. Additional genetic loci, as well as nongenetic factors such as lifestyle, sex, and age, have also been shown to play a role in modulating the clinical presentation of the disease. How each mutation results in hypertrophy and/or myofibrillar disarray is unclear. The present review discusses the current status of the molecular genetic characterization of this important disorder.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: October 15, 2002 / Accepted: November 18, 2002
Correspondence to:M.D. Bashyam
Rights and permissions
About this article
Cite this article
Bashyam, M., Savithri, G., Kumar, M. et al. Molecular genetics of familial hypertrophic cardiomyopathy (FHC). J Hum Genet 48, 55–64 (2003). https://doi.org/10.1007/s100380300007
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380300007
This article is cited by
-
Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study
BMC Cardiovascular Disorders (2017)
-
Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation
European Radiology (2011)
-
Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology
Acta Neuropathologica (2005)